Photo by Jeff Gray
Dr. Roger Glass, left, welcomes Drs. Freire and Yach to Fogarty.
Fogarty welcomed several new advisory board members during its September meeting. Lasker Foundation President Dr. Maria C. Freire and PepsiCo global health advisor Dr. Derek Yach will provide guidance on Fogarty funding awards and other activities. In addition, Dr. Kevin DeCock, new global health director at CDC, has joined the board in an ex officio capacity.
Dr. Maria C. Freire is the president of the Albert and Mary Lasker Foundation. Prior to that appointment, she was the CEO of the Global Alliance for TB Drug Development, which became the world leader in tuberculosis drug development under her leadership. Previously, Freire directed NIH's Office of Technology Transfer. Freire earned her undergraduate degree at Cayetano Heredia University in Lima, Peru and her Ph.D. in biophysics from the University of Virginia.
Dr. Derek Yach is senior vice president of global health policy at PepsiCo Inc., where he heads engagement efforts with major international policy and scientific groups. Previously he was responsible for global health initiatives at the Rockefeller Foundation and headed the division of global health at Yale University. As former executive director of the World Health Organization, he worked to advance issues including tobacco control, nutrition and chronic diseases.He received a master’s in public health from Johns Hopkins University, a master’s in epidemiology from the University of Stellenbosch in South Africa and his medical degree from the University of Cape Town.
Dr. Kevin M. DeCock was recently named director of CDC’s Center for Global Health. Throughout his career he has held a variety of positions and medical schools in the United Kingdom, the United States and sub-Saharan Africa. He most recently served as the Director of CDC Kenya. Previously, he was Director of the WHO Department of HIV/AIDS and led CDC's Division of HIV/AIDS Prevention, Surveillance, and Epidemiology. He received his medical degree in from the University of Bristol in the U.K., United Kingdom.
Comprised of scientists, physicians and representatives from the global health community, Fogarty’s advisory board provides advice on how the center’s resources may be most effectively used to advance research and research training in low-and middle-income countries.